课题基金 / 基金详情

Development of one-pot sequential cyclizations and applications towards the synthesis of complex alkaloids / Développement de cyclisations séquentielles monotopes et applications à la synthèse d'alcaloïdes complexes

Development of one-pot sequential cyclizations and applications towards the synthesis of complex alkaloids / Développement de cyclisations séquentielles monotopes et applications à la synthèse d'alcaloïdes complexes
一锅顺序环化的开发及其在复杂生物碱合成中的应用 / Développement de cyclations séquentielles monotopes et applications à la Synèse dalcaloïdes Complexes
批准号:
RGPIN-2017-05400
负责人:
Bélanger, Guillaume
金额:
$1.6万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-01-01 至 2021-12-31

项目摘要

项目成果

Bélanger, Guillaume的其他基金

相似基金

相关文献

中文摘要
翻译
该研究计划旨在开发原创策略,通过新的级联反应有效地合成复杂的天然产物。在这方面,拟议的研究分为三个方向(见下文)。这项拟议的研究计划将在有机化学家社区产生重大影响,因为它将提供创新和有效的方法来获得使用目前可用的方法难以获得的复杂生物碱和基序。这样的计划非常适合于制药行业和学术界的高素质人才的形成。 1-顺序Vilsmeier-Haack和有机催化的不对称Mannich环化。 在之前的Vilsmeier-Haack和Mannich环化级联项目(已发表)中,我们发现最后一步(Mannich)存在严重的局限性,例如亚胺离子的低反应性以及缺乏手性诱导。为了解决这两个问题,我们计划在带有非反应性酮或醛的底物上进行初始环化。然后加入催化量的仲胺将通过烯胺中间体引发第二环化(曼尼希)。催化剂负载量,底物范围以及手性诱导与不对称催化剂的使用将进行研究。 2-使用活化的氨基甲酸酯的新的环化顺序。 我们最近证明,在第二(曼尼希)环化反应中的相同反应性问题可以通过从氨基甲酸酯开始来解决。在活化和第一次环化之后,快速脱烷基化生成酰胺,该酰胺在过量活化剂的存在下原位再活化。所得的三氟锂离子比先前序列中的常规亚胺离子中间体反应性更强。因此,极大地促进了第二环化,这提高了该策略的适用性。底物和亲核试剂的范围将进行研究,以获得不同的氮杂双环和氮杂三环化合物的结构。 3-利用连续的Vilsmeier-Haack环化和分子内甲亚胺叶立德环加成完成复杂的多环生物碱的全合成。 这些合成利用一个连续的一锅Vilsmeier-Haack环化和分子内甲亚胺叶立德环加成。我们已经证明,这种策略是非常有效的,当应用于三个类的天然产物,即瑞香素,aspidospermans和aspidospermans的合成。在所有情况下,密钥转换都会生成高级中间体。我们现在需要从关键步骤加合物完成这些家族中的一系列靶向生物碱的合成,以证明我们对复杂天然产物的顺序环化的适用性。
英文摘要
This research program is aimed at developing original strategies to efficiently synthesize complex natural products through new cascades of reactions. In this vein, the research proposed is divided into three orientations (see below). This proposed research program will have a significant impact in the community of organic chemists since it will provide innovative and efficient ways to access complex alkaloids and motifs that are hard to obtain using the currently available methods. Such a program is perfectly suited for the formation of highly qualified personnel destined to pharmaceutical industry and academia. 1- Sequential Vilsmeier-Haack and organocatalyzed asymmetric Mannich cyclizations. In a previous project (published) on Vilsmeier-Haack and Mannich cyclizations cascade, we found serious limitations in the last step (Mannich), such as the low reactivity of the iminium ion as well as the absence of chiral induction. To address both of these issues, we plan to run the initial cyclization on substrates bearing an unreactive ketone or aldehyde. The addition of a catalytic amount of secondary amine will then trigger the second cyclization (Mannich) through an enamine intermediate. Catalyst loading, substrate scope as well as chiral induction with the use of asymmetric catalysts will be studied. 2- New sequence of cyclizations using activated carbamates. We recently demonstrated that the same reactivity issue in the second (Mannich) cyclization could be addressed by starting from a carbamate. After activation and first cyclization, a rapid dealkylation generates an amide that is reactivated in situ in the presence of an excess of activating agent. The resulting triflyliminium ion is substantially more reactive than regular iminiums ions intermediates in the previous sequence. The second cyclization is thus greatly facilitated, which improves the applicability of this strategy. Substrate and nucleophile scope will be studied to access architecturally varied aza-bicyclic and aza-tricyclic compounds. 3- Completion of the total synthesis of complex, polycyclic alkaloids using sequential Vilsmeier-Haack cyclization and intramolecular azomethine ylide cycloaddition. These syntheses exploit a sequential one-pot Vilsmeier-Haack cyclization and intramolecular azomethine ylide cycloaddition. We already proved that this strategy is highly efficient when applied to the synthesis of three classes of natural products, namely daphnanes, aspidospermans and aspidospermatans. In all cases, the key transformation generated an advanced intermediate. We now need to complete the syntheses of a series of targeted alkaloids in each of these families from the key step adducts to demonstrate the applicability our sequential cyclizations towards complex natural products.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of one-pot sequential cyclizations and applications towards the synthesis of complex alkaloids / Développement de cyclisations séquentielles monotopes et applications à la synthèse d'alcaloïdes complexes
  • 批准号:
    RGPIN-2017-05400
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.6万
  • 财政年份:
    2022
  • 负责人:
    Bélanger, Guillaume
  • 依托单位:
Substituted polyhydroquinolines from amino acids as templates for medicinal chemistry applications
  • 批准号:
    543675-2019
  • 项目类别:
    Collaborative Research and Development Grants
  • 资助金额:
    $0.85万
  • 财政年份:
    2021
  • 负责人:
    Bélanger, Guillaume
  • 依托单位:
Development of one-pot sequential cyclizations and applications towards the synthesis of complex alkaloids / Développement de cyclisations séquentielles monotopes et applications à la synthèse d'alcaloïdes complexes
  • 批准号:
    RGPIN-2017-05400
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.6万
  • 财政年份:
    2021
  • 负责人:
    Bélanger, Guillaume
  • 依托单位:
Substituted polyhydroquinolines from amino acids as templates for medicinal chemistry applications
  • 批准号:
    543675-2019
  • 项目类别:
    Collaborative Research and Development Grants
  • 资助金额:
    $0.85万
  • 财政年份:
    2020
  • 负责人:
    Bélanger, Guillaume
  • 依托单位:
国内基金
海外基金
光学影像POT地形阴影误差建模及形变测量应用
  • 批准号:
    42304039
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    丁超
  • 依托单位:
群体感应因子IQS引起宿主端粒保护蛋白POT1降解的机理研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2021
  • 负责人:
    王建和
  • 依托单位:
POT位点拷贝数变异与生物学年龄相关性及其在衰老中的作用机制
  • 批准号:
    81601211
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    17.0万元
  • 批准年份:
    2016
  • 负责人:
    张伟光
  • 依托单位:
POT1-TPP1保护端粒单链DNA的分子机制
  • 批准号:
    31500625
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2015
  • 负责人:
    武健
  • 依托单位: